Hutchison Medipharma Limited Company

HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
Industry: Genomic and Epigenominc Instabillity
Headquarters: China

Visit Website
info@hutch-med.com
Register and Claim Ownership